Clinical Trials Directory

Trials / Completed

CompletedNCT01864304

Fat Distribution and Glucose Metabolism in Williams Syndrome

Characterization of Fat Distribution and Glucose Metabolism in Individuals With and Without Williams Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
14 Years – 70 Years
Healthy volunteers
Accepted

Summary

Williams Syndrome (WS) is a genetic syndrome with features that may include vascular stenoses, neuro-developmental changes, and a variety of endocrine and metabolic abnormalities, including impaired glucose metabolism and abnormal body composition. Approximately 75% of adults with WS have impaired glucose tolerance or diabetes on oral glucose tolerance testing (OGTT). In addition, clinical observations and preliminary data suggest increased overall body fat in these individuals, as well as a relative increase in fat deposition in the lower extremities. However, glucose and lipid metabolism in WS remain incompletely characterized. The purpose of the current study is to carefully describe glucose metabolism and lipid parameters in people with WS.

Conditions

Timeline

Start date
2013-12-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2013-05-29
Last updated
2017-01-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01864304. Inclusion in this directory is not an endorsement.